Follow-up of patients with multidrug resistant tuberculosis four years after standardized first-line drug treatment
about
Multidrug-resistant tuberculosis (MDR-TB) disease burden in China: a systematic review and spatio-temporal analysisCharacteristics and treatment outcomes of patients with MDR and XDR tuberculosis in a TB referral hospital in Beijing: a 13-year experienceSurvival of civilian and prisoner drug-sensitive, multi- and extensive drug- resistant tuberculosis cohorts prospectively followed in RussiaEarly results of systematic drug susceptibility testing in pulmonary tuberculosis retreatment cases in Cameroon.Comparison of characteristics and mortality in multidrug resistant (MDR) and non-MDR tuberculosis patients in China.Persistently high prevalence of primary resistance and multidrug resistance of tuberculosis in Heilongjiang Province, China.Impact of Multidrug Resistance on Tuberculosis Recurrence and Long-Term Outcome in China.Burden of transmitted multidrug resistance in epidemics of tuberculosis: a transmission modelling analysis.Outcomes and follow-up of patients treated for multidrug-resistant tuberculosis in Orel, Russia, 2002-2005.Aggressive regimens for multidrug-resistant tuberculosis reduce recurrenceRisk factors for the treatment outcome of retreated pulmonary tuberculosis patients in China: an optimized prediction model.Genetic diversity, transmission dynamics and drug resistance of Mycobacterium tuberculosis in AngolaThe expression of ABC efflux pump, Rv1217c-Rv1218c, and its association with multidrug resistance of Mycobacterium tuberculosis in China.Estimated clinical impact of the Xpert MTB/RIF Ultra cartridge for diagnosis of pulmonary tuberculosis: A modeling study.Detecting drug-resistant tuberculosis: the importance of rapid testing.
P2860
Q28365342-45E28C7C-AB2A-4EB9-8258-5EA81B4D5BFDQ28478005-F462DD4F-C4C0-488F-96B3-0FE8960DF54AQ28478528-9FE0D569-2DBE-4839-AC28-E220B8FAB150Q34205098-67AD73A8-FCA4-4FAD-B840-FA2515C84E2DQ36131565-049E58F6-07B4-475C-B142-8EE4A4EE7995Q36145384-E8FB5B65-7599-463A-AF81-980843337BA0Q36258757-D2925F99-1D12-4B60-8A75-C84CF3A47D38Q36386227-D0499999-38D8-4B57-8856-D1FDA59FB06BQ36420040-D21FD236-527D-4DB9-A625-CEC43F3C91F2Q36638826-BD2658BA-1BA2-4068-824F-B7CD43E6DA35Q38842946-5E788284-19CA-4E6C-BA35-1E9762C874C6Q38946645-146AEBE9-0C99-4A69-8201-60096E64AF95Q39521856-D53C123B-CE73-4C06-AC63-4AC40DB4EB36Q47121800-8720E2EA-52C4-4197-ACD4-10031203F9CDQ51532520-AAC2D6D3-7185-4304-9EDC-7834E23357A7
P2860
Follow-up of patients with multidrug resistant tuberculosis four years after standardized first-line drug treatment
description
2010 nî lūn-bûn
@nan
2010 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Follow-up of patients with mul ...... ized first-line drug treatment
@ast
Follow-up of patients with mul ...... ized first-line drug treatment
@en
Follow-up of patients with mul ...... ized first-line drug treatment
@nl
type
label
Follow-up of patients with mul ...... ized first-line drug treatment
@ast
Follow-up of patients with mul ...... ized first-line drug treatment
@en
Follow-up of patients with mul ...... ized first-line drug treatment
@nl
prefLabel
Follow-up of patients with mul ...... ized first-line drug treatment
@ast
Follow-up of patients with mul ...... ized first-line drug treatment
@en
Follow-up of patients with mul ...... ized first-line drug treatment
@nl
P2093
P2860
P3181
P1433
P1476
Follow-up of patients with mul ...... ized first-line drug treatment
@en
P2093
Guang Xue He
Ji Huan Fan
Li Xia Wang
Martien W Borgdorff
Susan van den Hof
Xing Lu Yan
Xue Zhi Zhang
Yan Guang Xie
Yan Lin Zhao
P2860
P304
P3181
P356
10.1371/JOURNAL.PONE.0010799
P407
P577
2010-05-24T00:00:00Z